Get startedLog in
    Picture of Novakand Pharma AB logo

    NOVKAN — Novakand Pharma AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Novakand Pharma Q3 Net Sales Amounted To Sek 0 Million

    Picture of Novakand Pharma AB logoNovakand Pharma AB
    21/11/2025 07:13
    Nov 21 (Reuters) - Novakand Pharma AB NOVKAN.ST:

Q3 NET SALES AMOUNTED TO SEK 0 MILLION

Q3 RESEARCH AND DEVELOPMENT EXPENSES AMOUNTED TO SEK 4.0 MILLION

Q3 LOSS AFTER FINANCIAL ITEMS AMOUNTED TO SEK –23.1 MILLION

EQUITY ON SEPTEMBER 30, 2025 AMOUNTED TO SEK 20.0 MILLION

Source text: ID:nMFN4syWYz

Further company coverage: NOVKAN.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com;  +48 58 769 66 00;))

    Recent news on Novakand Pharma AB

    See all news